Fisher & Paykel Healthcare Corporation Limited (FSPKF)
OTCMKTS
· Delayed Price · Currency is USD
25.91
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
FSPKF Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 1,890 | 1,743 | 1,581 | 1,682 | 1,971 | 1,264 | Upgrade
|
| Revenue Growth (YoY) | 11.57% | 10.23% | -5.98% | -14.69% | 55.99% | 18.06% | Upgrade
|
| Cost of Revenue | 743.3 | 698.4 | 642.7 | 629 | 725.6 | 427.9 | Upgrade
|
| Gross Profit | 1,147 | 1,044 | 938.4 | 1,053 | 1,246 | 835.8 | Upgrade
|
| Selling, General & Admin | 516.7 | 492.8 | 431.9 | 393.1 | 396.6 | 338 | Upgrade
|
| Research & Development | 211.4 | 198.2 | 174.3 | 154 | 136.7 | 118.5 | Upgrade
|
| Operating Expenses | 728.1 | 691 | 606.2 | 547.1 | 533.3 | 456.5 | Upgrade
|
| Operating Income | 418.9 | 353.4 | 332.2 | 505.6 | 712.3 | 379.3 | Upgrade
|
| Interest Expense | -14.4 | -18.2 | -6.7 | -4.9 | -5 | -3.9 | Upgrade
|
| Interest & Investment Income | 3.6 | 3.3 | 2.6 | 2.6 | 1.5 | 2.2 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.5 | -4.7 | -0.1 | 0.9 | 9.4 | -7.1 | Upgrade
|
| EBT Excluding Unusual Items | 399.6 | 333.8 | 328 | 504.2 | 718.2 | 370.5 | Upgrade
|
| Asset Writedown | -98.1 | -98.1 | - | - | - | - | Upgrade
|
| Pretax Income | 301.5 | 235.7 | 328 | 504.2 | 718.2 | 370.5 | Upgrade
|
| Income Tax Expense | 123 | 103.1 | 77.7 | 127.3 | 194 | 83.2 | Upgrade
|
| Net Income | 178.5 | 132.6 | 250.3 | 376.9 | 524.2 | 287.3 | Upgrade
|
| Net Income to Common | 178.5 | 132.6 | 250.3 | 376.9 | 524.2 | 287.3 | Upgrade
|
| Net Income Growth | -31.79% | -47.02% | -33.59% | -28.10% | 82.46% | 37.33% | Upgrade
|
| Shares Outstanding (Basic) | 584 | 582 | 578 | 577 | 576 | 574 | Upgrade
|
| Shares Outstanding (Diluted) | 589 | 586 | 582 | 580 | 580 | 579 | Upgrade
|
| Shares Change (YoY) | 0.85% | 0.78% | 0.28% | 0.07% | 0.09% | 0.17% | Upgrade
|
| EPS (Basic) | 0.31 | 0.23 | 0.43 | 0.65 | 0.91 | 0.50 | Upgrade
|
| EPS (Diluted) | 0.30 | 0.23 | 0.43 | 0.65 | 0.90 | 0.50 | Upgrade
|
| EPS Growth | -32.54% | -47.44% | -33.85% | -28.10% | 82.26% | 37.02% | Upgrade
|
| Free Cash Flow | 413.6 | 112.8 | 50.4 | 185.9 | 465.1 | 176.1 | Upgrade
|
| Free Cash Flow Per Share | 0.70 | 0.19 | 0.09 | 0.32 | 0.80 | 0.30 | Upgrade
|
| Dividend Per Share | 0.420 | 0.415 | 0.405 | 0.395 | 0.380 | 0.275 | Upgrade
|
| Dividend Growth | 2.44% | 2.47% | 2.53% | 3.95% | 38.18% | 18.28% | Upgrade
|
| Gross Margin | 60.68% | 59.93% | 59.35% | 62.60% | 63.19% | 66.14% | Upgrade
|
| Operating Margin | 22.16% | 20.28% | 21.01% | 30.06% | 36.14% | 30.02% | Upgrade
|
| Profit Margin | 9.44% | 7.61% | 15.83% | 22.41% | 26.59% | 22.73% | Upgrade
|
| Free Cash Flow Margin | 21.88% | 6.47% | 3.19% | 11.05% | 23.59% | 13.94% | Upgrade
|
| EBITDA | 522.1 | 444.8 | 409.5 | 578.5 | 781.3 | 425.6 | Upgrade
|
| EBITDA Margin | 27.62% | 25.52% | 25.90% | 34.40% | 39.64% | 33.68% | Upgrade
|
| D&A For EBITDA | 103.2 | 91.4 | 77.3 | 72.9 | 69 | 46.3 | Upgrade
|
| EBIT | 418.9 | 353.4 | 332.2 | 505.6 | 712.3 | 379.3 | Upgrade
|
| EBIT Margin | 22.16% | 20.28% | 21.01% | 30.06% | 36.14% | 30.02% | Upgrade
|
| Effective Tax Rate | 40.80% | 43.74% | 23.69% | 25.25% | 27.01% | 22.46% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.